Structure-activity analysis of flavonoids: Direct and indirect antioxidant, and antiinflammatory potencies and toxicities

Nutrition and Cancer

Volumn 65, Issue 7, 2013, Pages 1014-1025

  Tsuji, Petra A ^a   Stephenson, Katherine K ^b   Wade, Kristina L ^b   Liu, Hua ^b   Fahey, Jed W ^b,c  

^a TOWSON UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' METHOXYFLAVONE; 3 METHOXYFLAVONE; 3',4' DIHYDROXYFLAVONE; 3,6 DIMETHOXYFLAVONE; 4' METHOXYFLAVONE; 5 HYDROXY,7 METHOXYFLAVANONE; 5 METHOXY,7 HYDROXYFLAVANONE; 5 METHOXYFLAVONE; 5,3' DIMETHOXYFLAVONE; 5,4' DIMETHOXYFLAVONE; 5,7 DIMETHOXYFLAVONE; 6,7 DIMETHOXYFLAVONE; 7 HYDROXYFLAVONE; 7 METHOXYFLAVONE; ALPHA NAPHTHOFLAVONE; ALPINETIN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA NAPHTHOFLAVONE; CHRYSIN; DIOSMETIN; FLAVONE; FLAVONOID; PINOCEMBRINE; PINOSTROBIN; PRIMULETIN; QUERCETIN; TECTOCHRYSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CELL PROTECTION; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; MICHAEL ADDITION; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BENZOTHIAZOLES; CACO-2 CELLS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOPREVENTION; FLAVONOIDS; HUMANS; INHIBITORY CONCENTRATION 50; LINEAR MODELS; LIPOPOLYSACCHARIDES; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS;

EID: 84888347424     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.809127     Document Type: Article

References (62)

1. Pietta PG: Flavonoids as antioxidants. Journal of Natural Products 63, 1035-1042, 2000.
2. Knekt P, J̈arvinen R, Reunanen A, and Maatela J: Flavonoid intake and coronary mortality in Finland: a cohort study. British Medical Journal 312, 478-481, 1996.
3. Spencer JPE: Metabolism of tea flavonoids in the gastrointestinal tract. Journal of Nutrition 133, 3255-3261, 2003.
4. Marchand LL, Murphy SP, Hankin JH,Wilkens LR, andKolonel LN: Intake of flavonoids and lung cancer. Journal of the National Cancer Institute 92, 154-160, 2000.
5. Knekt P, J̈arvinen R, Sepp̈anen R, Helïovaara M, Teppo L, et al.: Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. American Journal of Epidemiology 146, 223-230, 1997.
6. Hvattum E and Ekeberg D: Study of the collision-induced radical cleavage of flavonoid glucosides using negative electrospray ionization tandem quadrupole mass spectrometry. Journal of Mass Spectrometry 38, 43-49, 2003.
7. Ç elic H and Koşar M: Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: Structure-activity relationships. Chemico-Biological Interactions 197, 103-109, 2012.
8. Walle T, Hsieh F, DeLegge MH, Oatis JR, andWalle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition 32, 1377-1382, 2004.
9. Walle T: Absorption and metabolism of flavonoids. Free Radical Biology and Medicine 36, 829-837, 2004.
10. Asensi M, Medina I, Ortega A, Carretero J, Baño MC, et al.: Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biology and Medicine 33, 387-398, 2002.
11. WenXandWalle T: Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metabolism and Disposition 34, 1786-1792, 2006.
12. Tsuji PA and Walle T: Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish. Chemico-Biological Interactions 164, 85-92, 2006.
13. Manthey JA, Grohmann K, and Guthrie N: Biological properties of citrus flavonoids pertaining to cancer and inflammation. Current Medicinal Chemistry 8, 135-153, 2001.
14. Li S, Lo CY, and Ho CT: Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. Journal of Agricultural and Food Chemistry 54, 4176-4185, 2006.
15. Herz W and Sosa VE: Sesquiterpene lactones and other constituents of Arnica acaulis. Phytochemistry 27, 155-159, 1988.
16. Cavalcante SDH, Fernandes D, Paulino Fo HF, Yoshida M, and Gottlieb OR : Lignoids from the fruit of three Virola species. Phytochemistry 24, 1865-1866, 1985.
17. Santos LS, Correa MJC, Campos LMD, and Andiade MA: Constituents from the leaves of Virola michelli. Fitoterapia 67, 555-556, 1996.
18. Tawan C, Ipor IB, Fashihuddin BA, and Sani H: A brief account on the wild Piper (Piperaceae) of the Crocker Range, Sabah. ASEAN Review of Biodiversity and Environmental Conservation 1-11, 2002.
19. Ḧaberlein H and Tschiersch KP: On the occurrence of methylated and methoxylated flavonoids in Leptospermum scoparium. Biochemical Systematics and Ecology 26, 97-103, 1998.
20. Justesen U, and Knuthsen P: Composition of flavonoids in fresh herbs and calculation of flavonoid intake by use of herbs in traditional Danish dishes. Food Chemistry 73, 245-250, 2001.
21. Manthey JA, and Guthrie N: Antiproliferative activities of citrus flavonoids against six human cancer cell lines. Journal of Agricultural and Food Chemistry 50, 5837-5843, 2002.
22. Tsuji PAandWalle T: Inhibition of benzo[a]pyrene-activating enzymes and DNA-binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis 27, 1579-1585, 2006.
23. Moon Y,Wang X, andMorrisME: Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicology In Vitro 20, 187-210, 2006.
24. Dinkova-Kostova AT, Fahey JW, and Talalay P: Chemical structures of inducers of nicotinamide quinone oxidoreductase 1 (NQO1). Methods in Enzymology 382, 423-449, 2004.
25. Dinkova-Kostova AT, Cheah J, Samouilov A, Zweier JLA, Bozak RE, and Talalay P: Phenolic Michael recaction acceptors: combined direct and indirect antioxidant defenses against electrophiles and oxidants. Medicinal Chemistry 3, 261-268, 2007.
26. Gao X, Dinkova-Kostova AT, and Talalay P: Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. Proceedings of the National Academy of Sciences of the USA 98, 15221-15226, 2001.
27. Prestera T, Zhang Y, Spencer SR, Wilczak CA, and Talalay P: The electrophile counterattack response: protection against neoplasia and toxicity. Advances in Enzyme Regulation 33, 281-196, 1993.
28. Begleiter A, Sivananthan K, Lefas GM, Maksymiuk AW, and Bird RP: Inhibition of colon carcinogenesis by post-initiation induction of NQO1 in Sprague-Dawley rats. Oncology Reports 21, 1559-1565, 2009.
29. Choi EK, Terai K, Ji I-M, Kook YH, Park KH, et al.: Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells. Neoplasia 9, 634-642, 2007.
30. Dinkova-Kostova AT, and Talalay P: NAD(P)H:quionone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Archives Biochemica et Biophysica 501, 116-123, 2010.
31. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, and Talalay P: Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proceedings of the National Academy of Sciences of the USA 98, 3404-3409, 2001.
32. Fahey JW and Stephenson KK: Pinostrobin from honey and Thai ginger (Boesenbergia pandurata): a potent flavonoid inducer of mammalian phase 2 chemoprotective and antioxidant enzymes. Journal of Agricultural and Food Chemistry 50, 7472-7476, 2002.
33. Walle T, Ta N, Kawamori T, Wen X, Tsuji PA, et al.: Cancer chemopreventive properties of orally bioavailable flavonoids: methylated versus unmethylated flavones. Biochemical Pharmacology 79, 1288-1296, 2007.
34. Fahey JW, Dinkova-Kostova AT, Stephenson KK, and Talalay P: The "Prochaska" microtiter plate bioassay for inducers of NQO1. Methods in Enzymology 382, 243-258, 2004.
35. Vaidyanathan J andWalle T: Transport and metabolism of the tea flavonoid (?)-epicatechin by the human intestinal cell line Caco-2. Pharmaceutical Research 18, 1420-1425, 2001.
36. Reddel R, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, et al.: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Research 48, 1904-1909, 1988.
37. Liu H, Dinkova-Kostova AT, and Talalay P: Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles. Proceedings of the National Academy of Sciences of the USA 105, 15926-15931, 2008.
38. Sambuy Y, DeAngelis I, Ranaldi G, Scarino ML, Stammati A, et al.: The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biology and Toxicology 21(1), 1-26, 2005.
39. Hornberg C, Maciuleviciute L, and Seemayer NH: Human bronchoepithelial cells in vitro as a tool for detection of genotoxic activity of airborne particulates. Journal of Aerosol Sciences 27, S35-S36, 1996.
40. Forbes B: Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharmaceutical Science and Technology Today 3(1), 18-27, 2000.
41. Reilly CA, Taylor JL, Lanza DL, Carr BA, Crouch BA, et al.: Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors. Toxicology Sciences 73, 170-181, 2003.
42. Berge G, Ovrebo S, Botnen V, Hewer A, Phillips DH, et al.: Resveratrol inhibits benzo[a]pyrene-DNAadduct formation in human bronchial epithelial cells. British Journal of Cancer 91, 333-338, 2004.
43. Møllerup S, ∅vrebø S, and Haugen A: Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. International Journal of Cancer 92, 18-25, 2001.
44. Beckmann JD, Stewart A, KaiM, andKeeton TP : Controls of EGF-induced morphological transformation of human bronchial epithelial cells. Journal of Cellular Physioloy 189, 171-178, 2001.
45. Lin P, Chang YC, Chen CH, Yang WJ, Cheng YH, et al.: A comparative study on the effects of 2,3,7,8,-tetrachlorodibenzo-p-dioxin polychlorinated biphenyl 126 and estrogen in human bronchial epithelial cells. Toxicol Applied Pharmacology 195, 83-91, 2004.
46. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al.: Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150, 76-85, 1985.
47. Gerhauser C, Lee SK, Kosmeder JW, Moriarty RM, Hamel E, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Research 57, 272-278, 1997.
48. Tsuji PA andWalle T: Cytotoxic effects of the dietary flavones chrysin and apigenin in a normal trout liver cell line. Chemico-Biological Interactions 171, 37-44, 2008.
49. Biotium: MTT Cell Viability Assay Kit. Biotium, Inc., Hayward, CA, 2008.
50. Suh N, Honda T, Finlay HJ, Barchowsky A, Williams C, et al.: Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Research 58, 717-723, 1998.
51. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, and Langenhuijen MN: A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. Journal of Immunological Methods 174, 311-320, 1994.
52. Wakabayashi N, Slocum SL, Skoko JJ, Shin S, and Kensler TW: When NRF2 talks, who's listening? Antioxidants & Redox Signalling 13, 1649-1663, 2010.
53. Walle T: Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. International Journal of Molecular Sciences 10, 5002-5019, 2009.
54. Stoner G and Mukhtar H: Polyphenols as cancer chemopreventive agents. Journal of Cellular Biochemistry 22(Suppl), 169-180, 1995.
55. Harris GK, Qian Y, Leonard SS, Sbarra DC, and Shi X: Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. Journal of Nutrition 136, 1517-1521, 2006.
56. CanteroG, Campanella C, Mateos S, and Cort́es F: Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. Mutagenesis 21, 321-325, 2006.
57. Bensasson RV, Zoete V, Dinkova-Kostova AT, and Talalay P: Two-step mechanism of induction of the gene expression of a prototypic cancerprotective enzyme by diphenols. Chemical Research in Toxicology 21, 805-812, 2008.
58. Lee-Hilz YY, Boerboom A-MJF, Westphal AH, Berkel WJH, Aarts JM, and Rietjens IM: Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chemical Research in Toxicology 19, 1499-1505, 2006.
59. Uda Y, Price KR, Williamson G, and Rhodes MJC: Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids. Cancer Letters 120, 213-216, 1997.
60. Song LL, Kosmeder JW II, Lee SK, Gerḧauser C, Lantvit D, et al.: Cancer chemopreventive activity mediated by 4-bromoflavone, a potent inducer of phase II detoxification enzymes. Cancer Res 59, 578-585, 1999.
61. Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, et al.: Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proceedings of the National Academy of Sciences of the USA 102, 4584-4589, 2005.
62. Rice-Evans CA: Flavonoid antioxidants. Current Medicinal Chemistry 8, 797-807, 2001.